Do not try to "make up" for the missed dose
I understand tirzepatide is a dual-action GIP/GLP-1 agonist and may produce stronger weight loss results, while semaglutide has a longer track record
The following table breaks down key characteristics of various GLP-1 RAs, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, and Victoza, to give a clearer picture of their differences: This table elucidates the Ozempic vs Mounjaro debate, showing Mounjaros unique position with very high efficacy in both weight loss and blood sugar control
In clinical trials, people receiving Zepbound lost up to 21% of their starting body weight
But we just got the first good trial anddespite what you might have heardits not very encouraging
A wellness coach can guide you in setting small, specific goals or constructing new habits that stick